BioSpace News Archive

Meridian Bioscience, Inc. today provided preliminary net revenues results for its second quarter of fiscal 2022.

Iterative Scopes announced today that two new members have joined the leadership team: Brice Wu as Chief Product Officer, and Haig Soghigian as Vice President of the newly formed Customer Success team.

Avet Pharmaceuticals Inc. announced today the U.S. launch of its Propofol Injectable Emulsion, USP 10 mg/mL, in 20, 50 and 100 ml Single Patient-Use Vials, an AB rated generic equivalent of DIPRIVAN® (propofol) Injectable Emulsion USP, following its abbreviated new drug application approval from the Food and Drug Administration (FDA).

Clayton Pharmaceuticals, a thought leader and pioneer in developing innovative pathways to establish bioequivalence for complex generic drug products, announces that they have received FDA approval for Sucralfate Oral Suspension with Competitive Generic Therapy (CGT) designation.

IDbyDNA, the company revolutionizing the use of Precision Metagenomics, has been awarded a second year of funding by MRIGlobal to continue participation in the “Detect It with Gene Editing Technologies” program for the United States Defense Advanced Research Projects Agency.

Kynos is a spin-out from the University of Edinburgh (UoE), based on over a decade of research into KMO biology and its inhibitors.

Shanghai Henlius Biotech, Inc. announced that the United States Food and Drug Administration has granted Orphan-Drug Designation for HANSIZHUANG for the treatment of small cell lung cancer.

Zealand Pharma A/S announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders:

The ‘717 patent provides broad protection for Defence’s extremely versatile vaccine platform that can be incorporated into virtually any cell-based or protein subunit vaccine to enhance immunogenicity.

SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark for LeukoPrint® Molecular Karyotyping Kit and is now ready to launch this test in European markets.